Policy & Medicine

Legal, Regulatory, and Compliance Issues

facebook
twitter
google_plus
Email

Browsing daily archive

October 8, 2018

FDA Holds Public Meeting on Biosimilar Action Plan

CMS Announces 2019 Open Payment Reporting Thresholds

Open Payments
Litigation
FDA
CME
Opioids
International
State Policy
Transparency
COVID-19
CMS
MACRA

View Desktop Version